Cargando…
Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia
Metabolic reprogramming of cancer cells is a potential target for cancer therapy. It is also known that a hypoxic environment, one of the tumor microenvironments, can alter the energy metabolism from oxidative phosphorylation to glycolysis. However, the relationship between hypoxia and drug sensitiv...
Autores principales: | Yamaguchi, Atsushi, Mukai, Yuto, Sakuma, Tomoya, Narumi, Katsuya, Furugen, Ayako, Yamada, Yuma, Kobayashi, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883486/ https://www.ncbi.nlm.nih.gov/pubmed/36707650 http://dx.doi.org/10.1038/s41598-023-28558-4 |
Ejemplares similares
-
Mutual role of ecto-5'-nucleotidase/CD73 and concentrative nucleoside transporter 3 in the intestinal uptake of dAMP
por: Narumi, Katsuya, et al.
Publicado: (2019) -
Simple and validated method to quantify lacosamide in human breast milk and plasma using UPLC/MS/MS and its application to estimate drug transfer into breast milk
por: Furugen, Ayako, et al.
Publicado: (2023) -
Crucial Residue Involved in L-Lactate Recognition by Human Monocarboxylate Transporter 4 (hMCT4)
por: Sasaki, Shotaro, et al.
Publicado: (2013) -
Monocarboxylate transporters in cancer
por: Payen, Valéry L., et al.
Publicado: (2019) -
Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells
por: Cheng, Chang, et al.
Publicado: (2012)